NP/PA Connect
News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

Opinion|Videos|August 16, 2024

Balancing Vitiligo Treatments with Coverage Challenges

Author(s)Ted Lain, MD, MBA, FAAD

Ted Lain, MD, MBA, FAAD discusses balancing vitiligo treatments with coverage challenges.

Episodes in this series

EP. 1 Insights into Navigating the Emotional and Clinical Challenges in Vitiligo Management

EP. 1 Insights into Navigating the Emotional and Clinical Challenges in Vitiligo Management

EP. 2 Balancing Vitiligo Treatments with Coverage Challenges

EP. 2 Balancing Vitiligo Treatments with Coverage Challenges

EP. 3 Case-Based Insights: Addressing Location-Specific Concerns and Treatment Challenges in Vitiligo Management

EP. 3 Case-Based Insights: Addressing Location-Specific Concerns and Treatment Challenges in Vitiligo Management

EP. 4 Navigating the Treatment Paradigm for Vitiligo: Efficacy, MOA, and Long-Term Use of FDA-Approved Topical Ruxolitinib

EP. 4 Navigating the Treatment Paradigm for Vitiligo: Efficacy, MOA, and Long-Term Use of FDA-Approved Topical Ruxolitinib

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

A New Perspective on Seborrheic Dermatitis Management

ByMarie Bosslett, Assistant Editor

September 11th 2025

How to Individualize Biologic Therapy in Severe Prurigo Nodularis

ByKaitlyn Bader, Assistant Managing Editor

August 27th 2025

1 expert in this video

Importance of Shared Decision-Making and Tailored Treatment in Psoriasis Care

ByOmar Noor, MD, FAAD

August 6th 2025

1 expert in this video

Involving the Patient in Their Psoriasis Treatment With a 42-Year-Old Woman With a Busy Lifestyle

ByOmar Noor, MD, FAAD

August 6th 2025

1 expert in this video

Incorporating Patient Lifestyle into Treatment Decisions in a 64-Year-Old Man with Late-Onset Psoriasis

ByOmar Noor, MD, FAAD

August 6th 2025

Latest CME

Show Me the Data: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD

In-Person Event

Show Me the Data: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD

February 7, 2026

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Hilary Baldwin; Neal Bhatia, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Trending on Dermatology Times

Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis

Kyowa Kirin Takes Full Control of Rocatinlimab Program

Phase 2 TYK2 Inhibition Shows Promise in AD

Dermatology Times January 2026 Recap

The Rx Recap: January 25-30